HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective inhibition of interleukin-1 receptor-associated kinase 1 ameliorates lipopolysaccharide-induced sepsis in mice.

Abstract
Interleukin-1 receptor-associated kinases (IRAKs), particularly IRAK1 and IRAK4, are important in transducing signal from Toll-like receptor 4. We interrogated if a selective inhibition of IRAK1 could alleviate lipopolysaccharide (LPS)-induced sepsis. In this study, we tested the impact of a novel selective IRAK1 inhibitor Jh-X-119-01 on LPS-induced sepsis in mice. Survival at day 5 was 13.3% in control group where septic mice were treated by vehicle, while the values were 37.5% (p = 0.046, vs. control) and 56.3% (p = 0.003, vs. control) for 5 mg/kg and 10 mg/kg Jh-X-119-01-treated mice. Jh-X-119-01 alleviated lung injury and reduced production of TNFα and IFNγ in peritoneal macrophages. Jh-X-119-01 decreased phosphorylation of NF-κB and mRNA levels of IL-6 and TNFα in LPS-treated macrophages in vitro. Jh-X-119-01 selectively inhibited IRAK1 phosphorylation comparing with a non-selective IRAK1/4 inhibitor which simultaneously inhibited phosphorylation of IRAK1 and IRAK4. Both Jh-X-119-01 and IRAK1/4 inhibitor increased survival of septic mice, but Jh-X-119-01-treated mice had higher blood CD11b+ cell counts than IRAK1/4 inhibitor-treated ones [24 h: (1.18 ± 0.26) × 106/ml vs. (0.79 ± 0.20) × 106/ml, p = 0.001; 48 h: (1.00 ± 0.30) × 106/ml vs. (0.67 ± 0.23) × 106/ml, p = 0.042]. IRAK1/4 inhibitor induced more apoptosis of macrophages than Jh-X-119-01 did in vitro. IRAK1/4 inhibitor decreased protein levels of anti-apoptotic BCL-2 and MCL-1 in RAW 264.7 and THP-1 cells, an effect not seen in Jh-X-119-01-treated cells. In conclusion, Jh-X-119-01 selectively inhibited activation of IRAK1 and protected mice from LPS-induced sepsis. Jh-X-119-01 showed less toxicity on macrophages comparing with a non-selective IRAK1/4 inhibitor.
AuthorsBin Pan, Jun Gao, Wei Chen, Cong Liu, Longmei Shang, Mengdi Xu, Chunling Fu, Shengyun Zhu, Mingshan Niu, Kailin Xu
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 85 Pg. 106597 (Aug 2020) ISSN: 1878-1705 [Electronic] Netherlands
PMID32422509 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Elsevier B.V. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents
  • Benzamides
  • Cytokines
  • IRAK1 inhibitor Jh-X-119-01
  • Lipopolysaccharides
  • Pyrazoles
  • Pyridines
  • Interleukin-1 Receptor-Associated Kinases
  • Irak1 protein, mouse
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Apoptosis (drug effects)
  • Benzamides (pharmacology, therapeutic use)
  • Cell Line
  • Cytokines (immunology)
  • Humans
  • Interleukin-1 Receptor-Associated Kinases (antagonists & inhibitors, immunology)
  • Lipopolysaccharides
  • Lung (drug effects, immunology, pathology)
  • Macrophages (drug effects, immunology)
  • Male
  • Mice, Inbred C57BL
  • Pyrazoles (pharmacology, therapeutic use)
  • Pyridines (pharmacology, therapeutic use)
  • Sepsis (drug therapy, immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: